These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 30895307

  • 1. Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.
    Swanstrom JA, Nivarthi UK, Patel B, Delacruz MJ, Yount B, Widman DG, Durbin AP, Whitehead SS, De Silva AM, Baric RS.
    J Infect Dis; 2019 Jun 19; 220(2):219-227. PubMed ID: 30895307
    [Abstract] [Full Text] [Related]

  • 2. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
    Nivarthi UK, Kose N, Sapparapu G, Widman D, Gallichotte E, Pfaff JM, Doranz BJ, Weiskopf D, Sette A, Durbin AP, Whitehead SS, Baric R, Crowe JE, de Silva AM.
    J Virol; 2017 Mar 01; 91(5):. PubMed ID: 28031369
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dengue vaccine breakthrough infections reveal properties of neutralizing antibodies linked to protection.
    Henein S, Adams C, Bonaparte M, Moser JM, Munteanu A, Baric R, de Silva AM.
    J Clin Invest; 2021 Jul 01; 131(13):. PubMed ID: 34003796
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.
    VanBlargan LA, Mukherjee S, Dowd KA, Durbin AP, Whitehead SS, Pierson TC.
    PLoS Pathog; 2013 Jul 01; 9(12):e1003761. PubMed ID: 24348242
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dengue Virus Serotype 1 Conformational Dynamics Confers Virus Strain-Dependent Patterns of Neutralization by Polyclonal Sera.
    VanBlargan LA, Milutinovic PS, Goo L, DeMaso CR, Durbin AP, Whitehead SS, Pierson TC, Dowd KA.
    J Virol; 2021 Nov 09; 95(23):e0095621. PubMed ID: 34549976
    [Abstract] [Full Text] [Related]

  • 9. Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine.
    Magnani DM, Silveira CGT, Ricciardi MJ, Gonzalez-Nieto L, Pedreño-Lopez N, Bailey VK, Gutman MJ, Maxwell HS, Domingues A, Costa PR, Ferrari L, Goulart R, Martins MA, Martinez-Navio JM, Fuchs SP, Kalil J, Timenetsky MDC, Wrammert J, Whitehead SS, Burton DR, Desrosiers RC, Kallas EG, Watkins DI.
    J Virol; 2017 Nov 15; 91(22):. PubMed ID: 28878078
    [Abstract] [Full Text] [Related]

  • 10. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY, Durbin A, Tsai JJ, Hsieh SC, Whitehead S, Wang WK.
    J Virol; 2015 Jul 15; 89(14):7348-62. PubMed ID: 25972550
    [Abstract] [Full Text] [Related]

  • 11. Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes.
    Andrade DV, Katzelnick LC, Widman DG, Balmaseda A, de Silva AM, Baric RS, Harris E.
    mBio; 2017 Sep 19; 8(5):. PubMed ID: 28928210
    [Abstract] [Full Text] [Related]

  • 12. A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses.
    Wollner CJ, Richner M, Hassert MA, Pinto AK, Brien JD, Richner JM.
    J Virol; 2021 May 24; 95(12):. PubMed ID: 33762420
    [Abstract] [Full Text] [Related]

  • 13. Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus.
    Thomas A, Thiono DJ, Kudlacek ST, Forsberg J, Premkumar L, Tian S, Kuhlman B, de Silva AM, Metz SW.
    J Virol; 2020 Aug 31; 94(18):. PubMed ID: 32611757
    [Abstract] [Full Text] [Related]

  • 14. Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.
    Poddar A, Ramasamy V, Shukla R, Rajpoot RK, Arora U, Jain SK, Swaminathan S, Khanna N.
    BMC Biotechnol; 2016 Jun 14; 16(1):50. PubMed ID: 27301568
    [Abstract] [Full Text] [Related]

  • 15. Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1.
    Messer WB, Yount BL, Royal SR, de Alwis R, Widman DG, Smith SA, Crowe JE, Pfaff JM, Kahle KM, Doranz BJ, Ibarra KD, Harris E, de Silva AM, Baric RS.
    J Virol; 2016 May 15; 90(10):5090-5097. PubMed ID: 26962223
    [Abstract] [Full Text] [Related]

  • 16. Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.
    Uno N, Ross TM.
    J Virol; 2021 Jan 28; 95(4):. PubMed ID: 33208445
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.